{"id":"acrivastine","rwe":[{"pmid":"30000328","year":"2006","title":"Acrivastine.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"40220516","year":"2025","title":"Repurposing of activating transcription factor 3 (ATF3) activator molecules with potential wound-healing effects.","finding":"","journal":"Injury","studyType":"Clinical Study"},{"pmid":"39799798","year":"2025","title":"In-silico discovery of efficient second-generation drug derivatives with enhanced antihistamine potency and selectivity.","finding":"","journal":"Computational biology and chemistry","studyType":"Clinical Study"},{"pmid":"39723903","year":"2025","title":"Probing the Histamine H(1) Receptor Binding Site to Explore Ligand Binding Kinetics.","finding":"","journal":"Journal of medicinal chemistry","studyType":"Clinical Study"},{"pmid":"36883506","year":"2023","title":"DESIGN AND IN VITRO EVALUATION OF ACRIVASTINE AS ORODISPERSIBLE TABLET USING DIRECT COMPRESSION METHOD.","finding":"","journal":"Wiadomosci lekarskie (Warsaw, Poland : 1960)","studyType":"Clinical Study"}],"tags":[{"label":"Histamine-1 Receptor Antagonist","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Histamine H1 receptor","category":"target"},{"label":"HRH1","category":"gene"},{"label":"ABCB1","category":"gene"},{"label":"R06AX18","category":"atc"},{"label":"Active","category":"status"},{"label":"Allergic conjunctivitis","category":"indication"},{"label":"Allergic rhinitis","category":"indication"},{"label":"Common cold","category":"indication"},{"label":"Nasal congestion","category":"indication"},{"label":"Nasal discharge","category":"indication"},{"label":"Seasonal allergic rhinitis","category":"indication"},{"label":"Auxilium Pharms Inc","category":"company"},{"label":"Approved 1990s","category":"decade"},{"label":"Histamine Agents","category":"pharmacology"},{"label":"Histamine Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists","category":"pharmacology"},{"label":"Histamine H1 Antagonists, Non-Sedating","category":"pharmacology"},{"label":"Neurotransmitter Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":200.082,"date":"","count":37,"signal":"Total lung capacity increased","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=200)"},{"llr":186.534,"date":"","count":37,"signal":"Asthma-chronic obstructive pulmonary disease overlap syndrome","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=187)"},{"llr":175.991,"date":"","count":42,"signal":"Hypomania","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=176)"},{"llr":162.67,"date":"","count":42,"signal":"Jaundice cholestatic","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=163)"},{"llr":150.876,"date":"","count":37,"signal":"Nasal polyps","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=151)"},{"llr":144.657,"date":"","count":42,"signal":"Schizophrenia","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=145)"},{"llr":143.93,"date":"","count":37,"signal":"Sarcoidosis","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=144)"},{"llr":135.893,"date":"","count":38,"signal":"Rhinitis allergic","source":"DrugCentral FAERS","actionTaken":"Reported 38 times (LLR=136)"},{"llr":115.487,"date":"","count":37,"signal":"Cardiac murmur","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=115)"},{"llr":110.451,"date":"","count":37,"signal":"Bronchiectasis","source":"DrugCentral FAERS","actionTaken":"Reported 37 times (LLR=110)"},{"llr":103.541,"date":"","count":42,"signal":"Psychotic disorder","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=104)"},{"llr":93.647,"date":"","count":42,"signal":"Cholelithiasis","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=94)"},{"llr":93.291,"date":"","count":42,"signal":"Hepatotoxicity","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=93)"},{"llr":87.164,"date":"","count":42,"signal":"Blood bilirubin increased","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=87)"},{"llr":79.182,"date":"","count":32,"signal":"Lung neoplasm malignant","source":"DrugCentral FAERS","actionTaken":"Reported 32 times (LLR=79)"}],"commonSideEffects":[{"effect":"Somnolence","drugRate":"12%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"19%","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Palpitations","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Tachycardia","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Tremor","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Insomnia","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Nervousness","drugRate":"2%","severity":"common","organSystem":""}],"contraindications":["Angle-closure glaucoma","Benign prostatic hyperplasia","Coronary arteriosclerosis","Diabetes mellitus","Hypertensive disorder","Hypertensive urgency","Hyperthyroidism","Retention of urine"],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Angioedema","drugRate":"","severity":"serious"},{"effect":"Bronchospasm","drugRate":"","severity":"serious"},{"effect":"Erythema multiforme","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"company":"Auxilium Pharms Inc","patents":[],"pricing":[],"_fixedAt":"2026-03-30T16:29:27.778057","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=ACRIVASTINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:18:25.058335+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Acrivastine","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T00:18:31.880125+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:18:30.531231+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACRIVASTINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:18:30.837587+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Histamine H1 receptor antagonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:31.880050+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1224/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:18:31.539985+00:00"}},"allNames":"semprex-d","offLabel":[],"synonyms":["BW-270C","BW-825C","acrivastine","semprex"],"timeline":[{"date":"1994-03-25","type":"positive","source":"DrugCentral","milestone":"FDA approval (Auxilium Pharms Inc)"}],"brandName":"Semprex-D","ecosystem":[{"indication":"Allergic conjunctivitis","otherDrugs":[{"name":"alcaftadine","slug":"alcaftadine","company":"Allergan"},{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""}],"globalPrevalence":null},{"indication":"Allergic rhinitis","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Common cold","otherDrugs":[{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"azatadine","slug":"azatadine","company":""},{"name":"bromazine","slug":"bromazine","company":"Forest Labs"}],"globalPrevalence":null},{"indication":"Nasal congestion","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Nasal discharge","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"ammonium chloride","slug":"ammonium-chloride","company":"B Braun"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":30000000},{"indication":"Seasonal allergic rhinitis","otherDrugs":[{"name":"azatadine","slug":"azatadine","company":""},{"name":"azelastine","slug":"azelastine","company":"Meda Pharms"},{"name":"brompheniramine","slug":"brompheniramine","company":""},{"name":"carbinoxamine","slug":"carbinoxamine","company":"Mcneil"}],"globalPrevalence":null},{"indication":"Sneezing","otherDrugs":[{"name":"alimemazine","slug":"alimemazine","company":"Allergan Herbert"},{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"astemizole","slug":"astemizole","company":""},{"name":"azatadine","slug":"azatadine","company":""}],"globalPrevalence":null},{"indication":"Vasomotor rhinitis","otherDrugs":[{"name":"antazoline","slug":"antazoline","company":"Novartis"},{"name":"azatadine","slug":"azatadine","company":""},{"name":"azelastine","slug":"azelastine","company":"Meda Pharms"},{"name":"beclometasone dipropionate","slug":"beclometasone-dipropionate","company":""}],"globalPrevalence":null}],"mechanism":{"target":"Histamine H1 receptor","novelty":"Follow-on","targets":[{"gene":"HRH1","source":"DrugCentral","target":"Histamine H1 receptor","protein":"Histamine H1 receptor","isPrimary":true,"activityType":"IC50","activityValue":7.16},{"gene":"ABCB1","source":"DrugCentral","target":"Multidrug resistance protein 1","protein":"Multidrug resistance protein 1"}],"moaClass":"Histamine H1 Receptor Antagonists","modality":"Small Molecule","drugClass":"Histamine-1 Receptor Antagonist","explanation":"","oneSentence":"","technicalDetail":"Acrivastine competitively inhibits the histamine H1 receptor, preventing histamine from binding and triggering downstream signaling pathways involved in the allergic response."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Acrivastine","title":"Acrivastine","extract":"Acrivastine is a medication used for the treatment of allergies and hay fever. It is a second-generation H1-receptor antagonist antihistamine and works by blocking histamine H1 receptors."},"commercial":{"launchDate":"1994","_launchSource":"DrugCentral (FDA 1994-03-25, AUXILIUM PHARMS INC)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/82","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=ACRIVASTINE","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Acrivastine","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T08:26:18.438605","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:33.211522+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"cyproheptadine","drugSlug":"cyproheptadine","fdaApproval":"1961-10-17","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"antazoline","drugSlug":"antazoline","fdaApproval":"1990-04-30","relationship":"same-class"},{"drugName":"triprolidine","drugSlug":"triprolidine","fdaApproval":"1983-05-17","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"azatadine","drugSlug":"azatadine","fdaApproval":"1977-03-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-class"},{"drugName":"terfenadine","drugSlug":"terfenadine","fdaApproval":"","relationship":"same-class"},{"drugName":"loratadine","drugSlug":"loratadine","fdaApproval":"1993-04-12","genericCount":29,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketotifen","drugSlug":"ketotifen","fdaApproval":"1999-07-02","patentExpiry":"Mar 27, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"azelastine","drugSlug":"azelastine","fdaApproval":"1996-11-01","patentExpiry":"Jun 4, 2028","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"epinastine","drugSlug":"epinastine","fdaApproval":"2003-10-16","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fexofenadine","drugSlug":"fexofenadine","fdaApproval":"1996-07-25","patentExpiry":"Aug 2, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"desloratadine","drugSlug":"desloratadine","fdaApproval":"2001-12-21","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"acrivastine","indications":{"approved":[{"name":"Allergic conjunctivitis","source":"DrugCentral","snomedId":473460002,"regulator":"FDA"},{"name":"Allergic rhinitis","source":"DrugCentral","snomedId":61582004,"regulator":"FDA"},{"name":"Common cold","source":"DrugCentral","snomedId":82272006,"regulator":"FDA"},{"name":"Nasal congestion","source":"DrugCentral","snomedId":68235000,"regulator":"FDA"},{"name":"Nasal discharge","source":"DrugCentral","snomedId":64531003,"regulator":"FDA","usPrevalence":null,"globalPrevalence":30000000,"prevalenceMethod":"curated","prevalenceSource":"Influenza Other Respir Viruses, 2023 (PMID:36824394)"},{"name":"Seasonal allergic rhinitis","source":"DrugCentral","snomedId":367498001,"regulator":"FDA"},{"name":"Sneezing","source":"DrugCentral","snomedId":76067001,"regulator":"FDA"},{"name":"Vasomotor rhinitis","source":"DrugCentral","snomedId":8229003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"_fixedFields":["primaryTarget","pubmed(104)"],"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"cyproheptadine","brandName":"cyproheptadine","genericName":"cyproheptadine","approvalYear":"1961","relationship":"same-class"},{"drugId":"antazoline","brandName":"antazoline","genericName":"antazoline","approvalYear":"1990","relationship":"same-class"},{"drugId":"triprolidine","brandName":"triprolidine","genericName":"triprolidine","approvalYear":"1983","relationship":"same-class"},{"drugId":"azatadine","brandName":"azatadine","genericName":"azatadine","approvalYear":"1977","relationship":"same-class"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-class"},{"drugId":"terfenadine","brandName":"terfenadine","genericName":"terfenadine","approvalYear":"","relationship":"same-class"},{"drugId":"loratadine","brandName":"loratadine","genericName":"loratadine","approvalYear":"1993","relationship":"same-class"},{"drugId":"ketotifen","brandName":"ketotifen","genericName":"ketotifen","approvalYear":"1999","relationship":"same-class"},{"drugId":"azelastine","brandName":"azelastine","genericName":"azelastine","approvalYear":"1996","relationship":"same-class"},{"drugId":"epinastine","brandName":"epinastine","genericName":"epinastine","approvalYear":"2003","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000179060","MMSL":"4130","NDDF":"003921","UNII":"A20F9XAI7W","VUID":"4020857","CHEBI":"CHEBI:83168","VANDF":"4020857","INN_ID":"5548","RXNORM":"19959","UMLSCUI":"C0054340","chemblId":"CHEMBL1224","ChEMBL_ID":"CHEMBL1224","KEGG_DRUG":"D02760","DRUGBANK_ID":"DB09488","PUBCHEM_CID":"5284514","SNOMEDCT_US":"320813002","MESH_SUPPLEMENTAL_RECORD_UI":"C043648"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"1994-","companyName":"Auxilium Pharms Inc","relationship":"Original Developer"}],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"18%","fractionUnbound":"0.155%"},"publicationCount":104,"therapeuticAreas":["Infectious Disease"],"atcClassification":{"source":"DrugCentral","atcCode":"R06AX18","allCodes":["R06AX18"]},"biosimilarFilings":[],"originalDeveloper":"Auxilium Pharms Inc","recentPublications":[{"date":"2006","pmid":"30000328","title":"Acrivastine.","journal":""},{"date":"2025 Jun","pmid":"40220516","title":"Repurposing of activating transcription factor 3 (ATF3) activator molecules with potential wound-healing effects.","journal":"Injury"},{"date":"2025 Apr","pmid":"39799798","title":"In-silico discovery of efficient second-generation drug derivatives with enhanced antihistamine potency and selectivity.","journal":"Computational biology and chemistry"},{"date":"2025 Jan 9","pmid":"39723903","title":"Probing the Histamine H(1) Receptor Binding Site to Explore Ligand Binding Kinetics.","journal":"Journal of medicinal chemistry"},{"date":"2023","pmid":"36883506","title":"DESIGN AND IN VITRO EVALUATION OF ACRIVASTINE AS ORODISPERSIBLE TABLET USING DIRECT COMPRESSION METHOD.","journal":"Wiadomosci lekarskie (Warsaw, Poland : 1960)"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Auxilium Pharms Inc","companyId":"auxilium-pharms-inc","modality":"Small molecule","firstApprovalDate":"1994","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:18:33.211522+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":false,"score":2}}